COCHW Envoy Medical, Inc.
Fundamentals / CIK 0001840877 / USDEnvoy Medical, Inc. reported $231K in revenue and a net loss of $20.85M for the trailing twelve months ended September 30, 2026 (up 57.1% year over year), with a -352.8% gross margin and a -10343.3% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open COCHW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$231K +57.1% YoY
-
Operating Income TTM-$23.89M -10343.3% margin
-
Net Income TTM-$20.85M -9026.4% net margin
-
Diluted EPS TTM-$2.00 Split-adjusted
-
Free Cash Flow TTM-$18.38M -7956.7% FCF margin
-
Cash & ST Investments Sep 30, 2026$14.57M Total debt: --
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Revenue | $241K | $225K | $316K | $237K | -- |
| Cost of Revenue | $874K | $742K | $789K | $498K | -- |
| Gross Profit | -$633K | -$517K | -$473K | -$261K | -- |
| Research & Development | $12.49M | $10.18M | $8.96M | $4.97M | -- |
| Selling, General & Admin | $9.15M | $8.56M | $7.28M | $2.58M | -- |
| Operating Income | -$22.27M | -$19.26M | -$18.36M | -$8.71M | -$5.20M |
| EBITDA | -$21.97M | -$19.08M | -$18.23M | -$8.63M | -- |
| Interest Income | -- | -- | -- | $6.13M | $38K |
| Interest Expense | $1.59M | $816K | -- | -- | -- |
| Income Before Tax | -$23.76M | -$20.80M | -- | $20.74M | -$252K |
| Income Tax Expense | -- | -- | -- | $1.50M | -- |
| Net Income | -$23.76M | -$20.80M | -$29.92M | -$15.92M | -$252K |
| Basic EPS | -$12.30 | -$14.90 | -$25.40 | -$15.70 | -- |
| Diluted EPS | -$12.30 | -$14.90 | -$25.40 | -$15.70 | -- |
| Basic Shares Outstanding | 2.3M | 1.9M | 1.2M | 1.0M | -- |
| Diluted Shares Outstanding | 2.3M | 1.9M | 1.2M | 1.0M | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $66K | $51K | $39K | $75K | $42K | $78K | $46K | $42K |
| Cost of Revenue | $244K | $278K | $313K | $211K | $203K | $234K | $226K | $157K |
| Gross Profit | -$178K | -$227K | -$274K | -$136K | -$161K | -$156K | -$180K | -$115K |
| Research & Development | $3.08M | $3.13M | $3.64M | $4.55M | $2.70M | $2.48M | $2.75M | $2.47M |
| Selling, General & Admin | $2.28M | $2.21M | $2.04M | $2.14M | $2.40M | $2.43M | $2.18M | $1.96M |
| Operating Income | -$5.54M | -$5.57M | -$5.96M | -$6.83M | -$5.26M | -$5.07M | -$5.11M | -$4.55M |
| EBITDA | -$5.46M | -$5.50M | -$5.89M | -$6.75M | -$5.19M | -$4.99M | -$5.05M | -$4.50M |
| Interest Expense | -- | -- | -- | $0 | $471K | $624K | $495K | $384K |
| Net Income | -$3.93M | -$5.98M | -$4.35M | -$6.59M | -$6.48M | -$5.69M | -$5.00M | -$4.62M |
| Basic EPS | -$0.50 | -$0.70 | -$0.80 | -- | -$3.55 | -$3.20 | -$2.90 | -- |
| Diluted EPS | -$0.50 | -$0.70 | -$0.80 | -- | -$3.55 | -$3.20 | -$2.90 | -- |
| Basic Shares Outstanding | 10.4M | 10.4M | 6.9M | -- | 2.2M | 2.1M | 2.1M | -- |
| Diluted Shares Outstanding | 10.4M | 10.4M | 6.9M | -- | 2.2M | 2.1M | 2.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.74M | $5.48M | $4.22M | $183K | $150K | $25K |
| Cash & Short-Term Investments | $3.74M | $5.48M | $4.22M | $183K | $150K | $25K |
| Accounts Receivable, Net | $34K | $38K | $70K | $41K | -- | -- |
| Inventory | $1.55M | $1.71M | $1.40M | $1.29M | -- | -- |
| Total Current Assets | $6.28M | $8.90M | $7.46M | $1.65M | $863K | $25K |
| Property, Plant & Equipment, Net | $1.03M | $1.27M | $351K | $331K | -- | -- |
| Total Non-Current Assets | $2.28M | $2.64M | $815K | $908K | $426.0M | $95K |
| Total Assets | $8.56M | $11.54M | $8.27M | $2.56M | $426.9M | $120K |
| Accounts Payable | $2.92M | $1.65M | $1.55M | $1.00M | $619K | $96K |
| Other Current Liabilities | $518K | $573K | $645K | -- | -- | -- |
| Total Current Liabilities | $11.56M | $7.54M | $7.29M | $2.52M | $2.68M | $96K |
| Other Non-Current Liabilities | $27K | $891K | -- | $127K | -- | -- |
| Total Non-Current Liabilities | $8.76M | $22.84M | $2.76M | $36.23M | $35.94M | $0 |
| Total Liabilities | $20.32M | $30.38M | $10.05M | $38.75M | $38.62M | $96K |
| Total Debt (incl. Leases) | $919K | $945K | $600K | -- | -- | -- |
| Common Stock | $3.0K | $2.0K | -- | -- | -- | -- |
| Retained Earnings | -$313.4M | -$284.7M | -$257.3M | -$226.0M | -$36.71M | -$701 |
| Accumulated Other Comp. Income | -$120K | -$123K | -$118K | -$115K | -- | -- |
| Total Stockholders' Equity | -$12.16M | -$18.84M | -$1.78M | -$36.20M | -$44.96M | $24K |
| Total Equity | -$12.16M | -$18.84M | -$1.78M | -$36.20M | -$44.96M | $24K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $14.57M | $19.68M | $25.25M | $3.74M | $3.56M | $5.30M | $5.30M | $5.48M |
| Cash & Short-Term Investments | $14.57M | $19.68M | $25.25M | $3.74M | $3.56M | $5.30M | $5.30M | $5.48M |
| Accounts Receivable, Net | $51K | $49K | $31K | $34K | $35K | $43K | $42K | $38K |
| Inventory | $1.51M | $1.58M | $1.49M | $1.55M | $1.64M | $1.59M | $1.66M | $1.71M |
| Total Current Assets | $17.26M | $21.92M | $27.68M | $6.28M | $5.76M | $7.51M | $8.31M | $8.90M |
| Property, Plant & Equipment, Net | $854K | $921K | $962K | $1.03M | $1.12M | $1.14M | $1.22M | $1.27M |
| Total Non-Current Assets | $1.90M | $2.03M | $2.14M | $2.28M | $2.42M | $2.39M | $2.07M | $2.64M |
| Total Assets | $19.16M | $23.95M | $29.82M | $8.56M | $8.18M | $9.90M | $10.38M | $11.54M |
| Accounts Payable | $1.58M | $2.04M | $1.70M | $2.92M | $2.68M | $1.62M | $1.66M | $1.65M |
| Other Current Liabilities | $650K | $166K | $379K | $518K | $13K | $179K | $415K | $573K |
| Total Current Liabilities | $14.27M | $12.63M | $12.21M | $11.56M | $8.99M | $8.00M | $7.59M | $7.54M |
| Other Non-Current Liabilities | $27K | $27K | $27K | $27K | $891K | $891K | $891K | $891K |
| Total Non-Current Liabilities | $6.03M | $7.62M | $7.06M | $8.76M | $6.72M | $31.76M | $27.01M | $22.84M |
| Total Liabilities | $20.30M | $20.25M | $19.27M | $20.32M | $15.71M | $39.76M | $34.61M | $30.38M |
| Total Debt (incl. Leases) | -- | -- | -- | $919K | -- | -- | $923K | $945K |
| Common Stock | $8.0K | $8.0K | $8.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$331.6M | -$326.4M | -$319.1M | -$313.4M | -$305.7M | -$297.9M | -$291.0M | -$284.7M |
| Accumulated Other Comp. Income | -$123K | -$122K | -$121K | -$120K | -$120K | -$119K | -$117K | -$123K |
| Total Stockholders' Equity | -$1.53M | $3.30M | $10.16M | -$12.16M | -$7.66M | -$29.86M | -$24.22M | -$18.84M |
| Total Equity | -$1.53M | $3.30M | $10.16M | -$12.16M | -$7.66M | -$29.86M | -$24.22M | -$18.84M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$23.76M | -$20.80M | -$29.92M | $19.23M | -$252K |
| Depreciation & Amortization | $302K | $173K | $133K | $75K | -- |
| Stock-Based Compensation | $657K | $562K | $1.57M | $0 | -- |
| Change in Receivables | $4.0K | $32K | -$29K | $47K | -- |
| Change in Inventory | $126K | -$380K | -$10K | -$194K | -- |
| Change in Payables | $1.39M | -$19K | $551K | $342K | $618K |
| Operating Cash Flow | -$18.20M | -$17.95M | -$17.09M | -$8.80M | -$3.24M |
| Capital Expenditure | -$179K | -$980K | -$153K | -$218K | -- |
| Free Cash Flow | -$18.38M | -$18.93M | -$17.24M | -$9.02M | -- |
| Investing Cash Flow | -$179K | -$980K | -$153K | -$218K | -$425.0M |
| Common Stock Issued | $414K | -- | $109K | -- | -- |
| Dividends Paid | -$1.82M | -$2.45M | -- | -- | -- |
| Financing Cash Flow | $16.63M | $20.20M | $21.28M | $8.09M | $428.4M |
| Net Change in Cash | -$1.74M | $1.26M | $4.04M | -$938K | $125K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.93M | -$5.98M | -$4.35M | -$6.59M | -$6.48M | -$5.69M | -$5.00M | -$4.62M |
| Depreciation & Amortization | $75K | $74K | $73K | $80K | $76K | $85K | $61K | $48K |
| Stock-Based Compensation | $307K | $214K | $239K | $179K | $172K | $146K | $160K | $153K |
| Change in Receivables | -$2.0K | -$18K | $3.0K | $1.0K | $8.0K | -$1.0K | -$4.0K | $159K |
| Change in Inventory | $85K | -$103K | $44K | $125K | -$110K | $37K | $74K | -$143K |
| Change in Payables | -$433K | $308K | -$1.22M | $412K | $1.01M | -$43K | $10K | -$222K |
| Operating Cash Flow | -$5.03M | -$5.46M | -$6.06M | -$5.68M | -$4.33M | -$4.46M | -$3.73M | -$5.09M |
| Capital Expenditure | -- | -- | -- | -$172K | $0 | -$1.0K | -$6.0K | -- |
| Free Cash Flow | -- | -- | -- | -$5.86M | -$4.33M | -$4.46M | -$3.73M | -- |
| Investing Cash Flow | -- | -- | -- | -$172K | $0 | -$1.0K | -$6.0K | $534K |
| Common Stock Issued | $0 | $0 | $30.00M | -- | -- | -- | -- | -- |
| Dividends Paid | -- | -- | -- | $1.0K | $0 | -$607K | -$1.21M | -- |
| Financing Cash Flow | -$51K | -$109K | $27.57M | $6.04M | $2.60M | $4.44M | $3.55M | $5.62M |
| Net Change in Cash | -$5.11M | -$5.57M | $21.51M | $183K | -$1.73M | -$25K | -$171K | $1.06M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Gross Margin | -262.7% | -229.8% | -149.7% | -110.1% | -- |
| Operating Margin | -9240.7% | -8558.2% | -5809.8% | -3673.4% | -- |
| Net Profit Margin | -9857.3% | -9242.2% | -9469.0% | -6718.6% | -- |
| Return on Assets (ROA) | -277.6% | -180.2% | -361.8% | -623.0% | -0.1% |
| Current Ratio | 0.54x | 1.18x | 1.02x | 0.65x | 0.32x |
| Quick Ratio | 0.41x | 0.95x | 0.83x | 0.14x | 0.06x |
| Revenue Growth (YoY) | +7.1% | -28.8% | +33.3% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -352.8% | -385.5% | -310.7% | -262.7% | -294.2% | -262.2% | -284.4% | -229.8% |
| Operating Margin | -10343.3% | -11411.1% | -9881.2% | -9240.7% | -9611.1% | -8873.0% | -9188.7% | -8558.7% |
| Net Profit Margin | -9026.4% | -11304.8% | -9875.6% | -9857.3% | -10475.0% | -9579.3% | -9209.0% | -9242.2% |
| Return on Equity (ROE) | -- | -708.5% | -227.4% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -108.8% | -97.7% | -77.5% | -277.6% | -266.3% | -214.8% | -188.0% | -180.2% |
| Current Ratio | 1.21x | 1.73x | 2.27x | 0.54x | 0.64x | 0.94x | 1.09x | 1.18x |
| Quick Ratio | 1.10x | 1.61x | 2.14x | 0.41x | 0.46x | 0.74x | 0.88x | 0.95x |
| Revenue Growth (YoY) | +57.1% | -34.6% | -15.2% | +78.6% | -25.0% | +14.7% | -22.0% | -55.8% |